Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel spiro-containing dihydropyrimidine derivatives with antitumor activity. Efficient synthesis route offers cost reduction and scalability for pharmaceutical intermediates.
Novel patent CN108658931A offers high-yield route for Raltitrexed intermediate. Reduces toxic waste and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN112521348B details a green route for epoxysuccinic acid using titanium silicalite, eliminating heavy metals and reducing costs for water treatment and pharma sectors.
Patent CN101786983A reveals a mild one-pot synthesis for 2-amino-1,2-dihydroisoquinolines using AgOTF and NHC catalysts, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN104262167B reveals a mild metal phthalocyanine catalytic route for diarylamines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN117362311A reveals novel forskolin analogue synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN118056823A reveals a scalable route for high-purity Platinib intermediates. This process eliminates chromatography, ensuring cost reduction and supply reliability for pharmaceutical manufacturers.
Novel forskolin analogue synthesis via Pd-catalyzed coupling. Offers high purity pharmaceutical intermediates for oncology research and drug discovery.
Novel diazotization route avoids toxic cyanide. Scalable cosmetic intermediate manufacturing with high purity and reduced environmental impact.
Patent CN101883486B reveals non-chromatographic resolution. Enables cost reduction in pharmaceutical intermediate manufacturing via crystallization.
Patent CN108101842B reveals a one-pot synthesis for 2-hydroxy-4-carboxyquinoline, offering high purity, solvent recovery, and significant cost reduction in pharmaceutical manufacturing.
Patent CN111100101A reveals a low-cost mercury-catalyzed route for 3-benzofuranone compounds, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel patent CN118834163B enables high-yield synthesis of 4-tert-butyl-2-chloropyridine. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Advanced synthesis of (E)-2,4,5-trimethoxy-1-propenylbenzene via novel propionylation and dehydration. High purity >99%, low cost, scalable process for pharmaceutical intermediates.
Patent CN110396532A reveals enzymatic route for sialyllactose. High yield and low cost process ensures reliable supply chain for nutritional ingredients manufacturing globally.
Patent CN121318847A reveals optimized MAA synthesis reducing waste and cost. Enhances supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN1561333A details alpha-haloenamine reagents for efficient polyamide synthesis. Discover cost-effective, high-purity intermediates for DNA-binding applications.
Patent CN102241710A reveals efficient glycosylation routes for salidroside derivatives, offering cost-effective solutions for neuroprotective drug development and supply chain stability.
Novel Heck reaction route for HIV drug intermediate IDX-899. High selectivity, mild conditions, scalable manufacturing solution for pharmaceutical intermediates.
Patent CN108658871B details a continuous flow method for 4, 6-dichloro-5-methoxypyrimidine, offering high purity and reduced costs for API manufacturing.